Solasta Ventures
Home Approach Portfolio
News Team Hatchery Contact
HomeApproachPortfolio
Solasta Ventures
NewsTeamHatcheryContact
Bausch + Lomb and Clearside Biomedical Announce FDA Approval of XIPERE™
Nia JulianOctober 27, 2021
Facebook0 Twitter Pinterest0 0 Likes
Previous

Moderna and Carisma Establish Collaboration to Develop in vivo Engineered Chimeric Antigen Receptor Monocytes (CAR-M) for Oncology

Nia JulianJanuary 11, 2022
Next

Xilio Therapeutics Announces Pricing of Initial Public Offering

Nia JulianOctober 25, 2021

© 2020 Solasta Ventures. All Rights Reserved.